🇺🇸 FDA
Patent

US 11524948

Prodrugs of alpha-ketoglutarate, alpha-ketobutyrate, alpha-ketoisovalerate, and alpha-ketoisohexanoate, and uses thereof

granted A61KA61K31/22A61K31/357

Quick answer

US patent 11524948 (Prodrugs of alpha-ketoglutarate, alpha-ketobutyrate, alpha-ketoisovalerate, and alpha-ketoisohexanoate, and uses thereof) held by The Regents of the University of California expires Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/22, A61K31/357, A61K31/6615, A61P